Joonghyun Shim | Biochemistry, Genetics and Molecular Biology | Innovative Research Award

Published on by Forensic Scientist Awards

Innovative Research Award

Joonghyun Shim
Seoul Women’s University, South Korea

Joonghyun Shim
Affiliation Seoul Women’s University
Country South Korea
Scopus ID 57030605400
Documents 34
Citations 636
h-index 14
Subject Area Biochemistry, Genetics and Molecular Biology
Event International Forensic Scientist Awards
ORCID 0000-0003-1025-2722

Joonghyun Shim is a researcher affiliated with Seoul Women’s University whose documented scholarly profile is situated within biochemistry, genetics and molecular biology. The research record includes investigations into cellular responses, natural-product-derived compounds and molecular mechanisms associated with skin biology and aging. Bibliographic information identifies 34 documents, 636 citations and an h-index of 14. [1]

Abstract

Joonghyun Shim’s research profile encompasses molecular and cellular investigations relevant to skin biology, pigmentation, photoaging and biochemical signaling. The documented publications examine mechanisms through which bioactive compounds and inflammatory or oxidative pathways influence dermal fibroblasts and melanogenesis. Recent work on Phycodris fimbriata extract evaluates UVA-associated photoaging through antioxidant enzymes and the ERK1/2 pathway, while earlier studies investigated cycloheterophyllin, gyrophoric acid and prostaglandin E2-related signaling. [2] [3] [4] [5]

Keywords

  • Biochemistry
  • Molecular Biology
  • Dermal Fibroblasts
  • Photoaging
  • Melanin Synthesis

Introduction

Research addressing molecular mechanisms of skin aging and pigmentation integrates biochemistry, cellular biology and natural-product research. Shim’s listed publications contribute to this area by examining cellular signaling, antioxidant responses and biochemical pathways in human dermal fibroblasts and melanogenesis models. The work provides a research context connecting molecular mechanisms with experimentally investigated bioactive substances. [3] [4]

Research Profile

The research profile is characterized by experimental investigation of molecular pathways associated with cellular aging, pigmentation and responses to environmental stress. The 2026 publication on UVA-induced photoaging examines antioxidant enzymes and ERK1/2 signaling in dermal fibroblasts, representing a recent extension of this research direction. [2]

Research Contributions

The documented studies address complementary mechanisms: inhibition of melanin synthesis, cellular responses to UVA exposure, anti-aging activity of gyrophoric acid, and prostaglandin E2 signaling through the E-prostanoid 1 receptor. [3] [4] [5] Collectively, these publications demonstrate a consistent interest in molecular mechanisms that can be investigated through biochemical and cellular approaches.

Publications

  • Phycodris Fimbriata Extract Attenuates UVA-Induced Photoaging in Dermal Fibroblasts by Modulating Antioxidant Enzymes and ERK1/2 Pathway. Current Issues in Molecular Biology, 2026. [2]
  • Inhibitory Effects of Cycloheterophyllin on Melanin Synthesis. Molecules, 2021. [3]
  • Anti-Aging Effects of Gyrophoric Acid on UVA-Irradiated Normal Human Dermal Fibroblasts. Natural Product Communications, 2020. [4]
  • Prostaglandin E2 Induces Skin Aging via E-Prostanoid 1 in Normal Human Dermal Fibroblasts. International Journal of Molecular Sciences, 2019. [5]

Research Impact

The available bibliometric record reports 34 documents, 636 citations and an h-index of 14, providing quantitative indicators of the visibility of the research output. [1] These indicators should be interpreted alongside publication quality, methodological contribution, reproducibility and relevance to the field rather than as standalone measures of research significance.

Award Suitability

The documented publication record aligns with an Innovative Research Award profile through its focus on experimentally investigated molecular mechanisms and bioactive compounds. The research spans pigmentation, oxidative stress, photoaging and signaling pathways, offering a coherent subject-area connection to biochemistry and molecular biology. Award consideration can be informed by the documented publications, research metrics and independent assessment of originality and contribution.

Conclusion

Joonghyun Shim’s academic profile combines measurable bibliometric activity with a focused body of molecular and cellular research. The cited studies provide evidence of sustained investigation into skin-related biochemical mechanisms, while the reported Scopus indicators offer a quantitative overview of research visibility. [1]

References

  1. Elsevier. (n.d.). Scopus author details: Joonghyun Shim, Author ID 57030605400. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=57030605400
  2. Shim, J. (2026). Phycodris Fimbriata Extract Attenuates UVA-Induced Photoaging in Dermal Fibroblasts by Modulating Antioxidant Enzymes and ERK1/2 Pathway. Current Issues in Molecular Biology.
    https://doi.org/10.3390/cimb48100971
  3. Shim, J. (2021). Inhibitory Effects of Cycloheterophyllin on Melanin Synthesis. Molecules.
    https://doi.org/10.3390/molecules26092526
  4. Shim, J. (2020). Anti-Aging Effects of Gyrophoric Acid on UVA-Irradiated Normal Human Dermal Fibroblasts. Natural Product Communications.
    https://doi.org/10.1177/1934578X20919545
  5. Shim, J. (2019). Prostaglandin E2 Induces Skin Aging via E-Prostanoid 1 in Normal Human Dermal Fibroblasts. International Journal of Molecular Sciences.
    https://doi.org/10.3390/ijms20225555

Khaled M. Zayed | Biochemistry, Genetics and Molecular Biology | Research Excellence Award

Published on by Forensic Scientist Awards

Research Excellence Award

Khaled M. Zayed
Theodor Bilharz Research Institute, Egypt
Khaled M. Zayed
Affiliation Theodor Bilharz Research Institute
Country Egypt
Scopus ID 56028514700
Documents 22
Citations 128
h-index 7
Subject Area Biochemistry, Genetics and Molecular Biology
Event International Forensic Scientist Awards

Khaled M. Zayed is a researcher affiliated with the Theodor Bilharz Research Institute in Egypt, with scholarly contributions associated with biochemistry, genetics and molecular biology. His indexed research record includes investigations involving nanotechnology, biological activity, parasitic disease research, immunomodulation and related biomedical applications. Based on the supplied Scopus profile indicators, his publication record comprises 22 documents, 128 citations and an h-index of 7, reflecting a developing research impact within his scientific areas of contribution. [1]

Abstract

This article presents an academic overview of Khaled M. Zayed and his research profile in relation to the Research Excellence Award category. His work reflects interdisciplinary engagement across biomedical sciences, biological activity studies, nanomaterials and disease-oriented research. Recent publication activity includes work on green-synthesized nanoparticles derived from the Egyptian edible bivalve Paratapes undulatus and research concerning olive oil nanoemulsions with antischistosomal and immunomodulatory potential. [2] [3]

Keywords

Research Excellence Award; Khaled M. Zayed; biomedical research; nanotechnology; biochemistry; molecular biology; immunomodulation; antischistosomal research; green synthesis; scientific publications.

Introduction

Research excellence is commonly assessed through sustained scholarly activity, scientific relevance, publication output and the contribution of research findings to disciplinary knowledge. Within biomedical and molecular sciences, interdisciplinary approaches increasingly combine natural products, nanotechnology and biological evaluation. Zayed’s research profile is situated within this broader scientific environment and demonstrates engagement with applied and experimental research themes. [1]

Research Profile

Khaled M. Zayed’s indexed scholarly record identifies him with research activities in biochemistry, genetics and molecular biology. His institutional affiliation with the Theodor Bilharz Research Institute connects his work with biomedical and disease-focused scientific investigation. The available publication indicators show 22 indexed documents and 128 citations, with an h-index of 7. [1]

Research Contributions

  • Investigation of green-synthesized nanoparticles and their in vitro biological potential.
  • Participation in research on nanoemulsion preparation and physicochemical characterization.
  • Contribution to antischistosomal and immunomodulatory research applications.
  • Interdisciplinary work connecting natural resources, nanotechnology and biomedical evaluation. [2] [3]

Publications

Among the recent listed research outputs are the 2026 Scientific Reports article, “In vitro biological potential of green-synthesized nanoparticles from the Egyptian edible bivalve Paratapes undulatus (Born, 1778),” and the 2026 article “Preparation and Physicochemical Characterization of an Olive Oil Nanoemulsion with Antischistosomal and Immunomodulatory Activity” in the Egyptian Journal of Chemistry. These publications illustrate continuing engagement with emerging materials and biomedical applications. [2] [3]

Research Impact

Citation and publication indicators provide one perspective on scholarly visibility and research dissemination. With 22 indexed documents, 128 citations and an h-index of 7, the available Scopus metrics indicate measurable recognition of the research record. Such indicators should be interpreted alongside subject specialization, publication context and the qualitative contribution of individual research outputs. [1]

Award Suitability

The research profile demonstrates relevance to recognition under a Research Excellence Award category associated with the International Forensic Scientist Awards. Suitability may be considered on the basis of publication activity, interdisciplinary biomedical research, scientific contributions involving biological and nanotechnological applications, and documented scholarly impact. Final recognition remains subject to the evaluation criteria and selection procedures established by the awarding organization. [4]

Conclusion

Khaled M. Zayed’s academic profile reflects research activity spanning biomedical science, nanotechnology and biological applications. His indexed publications and citation record provide evidence of sustained scholarly participation, while recent studies demonstrate continued engagement with contemporary experimental research. The profile presents a documented basis for consideration within an academic research recognition framework. [1]

References

  1. Elsevier. (n.d.). Scopus author details: Khaled M. Zayed, Author ID 56028514700. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=56028514700
  2. El Makawy, A. I., Zayed, K. M., Mabrouk, D. M., Hussien, A. G., Fahmy, C. A., et al. (2026). In vitro biological potential of green-synthesized nanoparticles from the Egyptian edible bivalve Paratapes undulatus (Born, 1778). Scientific Reports. DOI information available through the publisher and article indexing services.
  3. Dokmak, H. A. A. S., Ramadan, M. A., Faid, A. H., El-Ashkar, A. M., Abdelmaksoud, H. F., et al. (2026). Preparation and Physicochemical Characterization of an Olive Oil Nano emulsion with Antischistosomal and Immunomodulatory Activity. Egyptian Journal of Chemistry.
  4. International Forensic Scientist Awards. (n.d.). International Forensic Scientist Awards: Academic recognition and scientific achievement.
    forensicscientist.org

Isidoro Feliciello | Biochemistry, Genetics and Molecular Biology | Innovative Research Award

Published on by Forensic Scientist Awards

Innovative Research Award

Isidoro Feliciello
University of Naples Federico II, Italy

Isidoro Feliciello
Affiliation University of Naples Federico II
Country Italy
Scopus ID 6506469897
Documents 42
Citations 986
h-index 17
Subject Area Biochemistry, Genetics and Molecular Biology
Event International Forensic Scientist Awards
ORCID 0000-0002-2588-9366

Isidoro Feliciello is a researcher affiliated with the University of Naples Federico II whose scholarly work contributes to the fields of molecular biology, genetics, epigenetics, genome regulation, and biomedical research. His publication record demonstrates sustained engagement with investigations involving satellite DNA, gene expression regulation, cancer biomarkers, retrotransposons, and microbial biotechnology. Through peer-reviewed publications and collaborative scientific studies, he has contributed to advancing understanding of molecular mechanisms relevant to human health and disease.[1]

Abstract

This article presents an academic overview of Isidoro Feliciello and his research contributions in molecular biology and genetics. His work encompasses investigations into alpha-satellite DNA, genome regulation, cancer-related biomarkers, transcriptional control mechanisms, and translational biomedical applications. Recent studies have explored extracellular alpha-satellite DNA as a potential biomarker for bladder cancer detection and the regulatory effects of alpha-satellite transcripts on gene expression.[2]

Keywords

Alpha-Satellite DNA, Molecular Genetics, Gene Regulation, Cancer Biomarkers, Epigenetics, Digital PCR, Genome Biology, Biomedical Research.

Introduction

Research in biochemistry and molecular genetics continues to expand knowledge regarding genomic organization, transcriptional regulation, and disease mechanisms. Within this context, Isidoro Feliciello has contributed to studies that investigate repetitive DNA sequences, cellular regulatory pathways, and molecular indicators associated with disease diagnosis and progression.[3]

Research Profile

According to available scholarly metrics, the researcher has produced 42 indexed documents with 986 citations and an h-index of 17. His academic portfolio reflects interdisciplinary engagement spanning molecular biology, genetics, cancer biology, nucleic acid regulation, and biotechnology. Publications appear in recognized international journals and demonstrate continued participation in contemporary scientific discourse.[1]

Research Contributions

  • Investigation of alpha-satellite DNA dynamics and biological functions.
  • Research on transcriptional regulation and gene expression mechanisms.
  • Development of molecular approaches for cancer biomarker identification.
  • Studies involving genome integration, retrotransposons, and nucleic acid biology.
  • Contributions to antimicrobial and biotechnology-related applications.

Publications

Selected publications include studies on extracellular alpha-satellite DNA as a candidate biomarker for bladder cancer detection, downregulation of gene expression by alpha-satellite transcripts, chemoresistance mechanisms involving G-quadruplex ligands, antibacterial effects of phenylboronic acid, and analyses concerning polyadenylation and LINE-1 retrotransposons.[2]

Research Impact

The citation profile and publication record indicate meaningful scholarly visibility within molecular biology and genetics. Research outputs address biologically relevant questions concerning genomic structure, gene regulation, cancer diagnostics, and translational biomedical applications. Such contributions support ongoing scientific efforts aimed at improving understanding of complex cellular processes and disease-related molecular signatures.[4]

Award Suitability

The Innovative Research Award recognizes individuals demonstrating sustained scholarly productivity, scientific originality, and measurable research impact. Based on publication activity, citation performance, and contributions to molecular genetics and biomedical research, Isidoro Feliciello exhibits characteristics consistent with the objectives of the International Forensic Scientist Awards recognition framework. His work reflects continued engagement with innovative scientific questions and emerging molecular methodologies.[5]

Conclusion

Isidoro Feliciello’s research portfolio demonstrates sustained contributions to molecular biology, genetics, and biomedical sciences. Through studies addressing genome regulation, cancer biomarkers, and nucleic acid biology, he has contributed to the advancement of scientific understanding in several interconnected research domains. His scholarly record provides a foundation for recognition within international research and innovation award programs.[6]

References

  1. Elsevier. (n.d.). Scopus author details: Isidoro Feliciello, Author ID 6506469897. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=6506469897
  2. Feliciello, I. et al. (2026). Extracellular Alpha-Satellite DNA in Human Plasma as a Candidate Biomarker for Bladder Cancer Detection.
    https://doi.org/10.3390/ijms27156834
  3. Feliciello, I. et al. (2025). Downregulation of Gene Expression by Alpha Satellite Transcripts.
    https://doi.org/10.3390/ijms262211204
  4. Feliciello, I. et al. (2025). Reversing uL3-mediated Chemoresistance Through Synergistic Combination of 5-FU and G-Quadruplex Ligands.
    https://doi.org/10.1093/narcan/zcaf046
  5. Feliciello, I. et al. (2025). Antibacterial Effect of Phenylboronic Acid on Escherichia coli.
    https://doi.org/10.17113/ftb.63.01.25.8771
  6. Feliciello, I. et al. (2025). Role of Polyadenylation in mRNA Genome Integration via LINE-1 Retrotransposons.
    https://doi.org/10.31083/FBS26335

Darren Powell | Biochemistry | Innovative Research Award

Published on by Forensic Scientist Awards

Innovative Research Award

Darren Powell
Affiliation Alder Hey Children’s NHS Trust
Country United Kingdom
Google Scholar ID G_iJ7f4AAAAJ
Citations 1297
h-index 17
i10-index 28
Subject Area Biochemistry
Event International Forensic Scientist Awards
ORCID 0000-0001-9439-5880

Darren Powell
Alder Hey Children’s NHS Trust

The Innovative Research Award profile recognizes the scholarly contributions of Darren Powell, a researcher affiliated with Alder Hey Children’s NHS Trust in the United Kingdom. His academic work in the field of biochemistry has contributed to the advancement of scientific understanding through peer-reviewed publications, interdisciplinary collaboration, and knowledge dissemination across biomedical and clinical research domains.[1] The available citation metrics indicate sustained academic engagement and measurable research influence within relevant scientific communities.[2]

Abstract

This article presents an academic recognition profile of Darren Powell, highlighting research achievements, scholarly influence, publication activity, and contributions within the field of biochemistry. The profile evaluates objective indicators including citation performance, publication visibility, research dissemination, and engagement with scientific communities. Such metrics are commonly considered during the assessment of candidates for scholarly recognition and innovation-oriented awards.[2][3]

Keywords

Biochemistry, Research Innovation, Scientific Impact, Scholarly Publications, Citation Analysis, Research Excellence, Biomedical Science, Academic Recognition, Translational Research, Knowledge Dissemination.

Introduction

Academic awards are frequently used to acknowledge individuals who demonstrate sustained contributions to scientific advancement, innovation, and knowledge generation. Within the biochemistry discipline, researchers play an essential role in improving the understanding of biological systems, disease mechanisms, and translational applications relevant to healthcare and scientific progress.[4] Darren Powell’s scholarly profile reflects participation in these broader objectives through research activities associated with a leading healthcare institution in the United Kingdom.[1]

Research Profile

Darren Powell is affiliated with Alder Hey Children’s NHS Trust and has established a visible academic presence through scholarly publications and citation-based research metrics. His Google Scholar profile reports 1,297 citations, an h-index of 17, and an i10-index of 28, indicating both productivity and measurable influence within the scientific literature.[2] These indicators suggest consistent engagement with topics relevant to biochemistry and associated biomedical research areas.[5]

Research Contributions

The research contributions attributed to Darren Powell demonstrate participation in scientific investigations that support evidence-based practice and the advancement of biochemical knowledge. Through publication activity and scholarly collaboration, his work has contributed to the accumulation of scientific evidence that informs ongoing research and clinical applications.[3] The visibility of his research outputs, reflected by citation activity, indicates that published findings have been referenced by other investigators within related fields.[5]

Publications

The publication record associated with Darren Powell includes peer-reviewed scientific outputs contributing to the broader literature in biochemistry and biomedical sciences. Scholarly publications remain a primary mechanism through which research findings are validated, communicated, and incorporated into future investigations.[6] Continued citation activity demonstrates the ongoing relevance of published work within the scientific ecosystem.[2]

Research Impact

Research impact may be evaluated using a combination of citation metrics, scholarly visibility, collaboration networks, and contributions to knowledge advancement. Citation counts, h-index values, and publication influence collectively indicate that Darren Powell’s research has attracted attention from fellow researchers and has contributed to ongoing scientific dialogue.[2][5] Such measures are frequently considered in assessments of research excellence and innovation.

Award Suitability

Based on available academic indicators, Darren Powell demonstrates characteristics commonly associated with candidates for research recognition programs. These include sustained publication activity, measurable citation impact, engagement with scientific communities, and contributions within the biochemistry discipline.[2] Consideration for the Innovative Research Award is consistent with the objective evaluation of scholarly productivity and research influence.

Conclusion

Darren Powell’s academic profile reflects active participation in biochemistry research and sustained scholarly engagement through publications and citations. His research metrics, institutional affiliation, and contribution to scientific knowledge provide a foundation for consideration within academic recognition frameworks. Continued research activity and dissemination of findings are expected to further strengthen scholarly impact and visibility.[1][2]

References

    1. Alder Hey Children’s NHS Foundation Trust. (n.d.). Institutional research and clinical innovation activities.
      https://www.alderhey.nhs.uk
    2. Google Scholar. (n.d.). Scholar metrics and citation indicators for researcher profiles.
      https://scholar.google.com
    3. National Center for Biotechnology Information. (2021). Research dissemination and scientific communication.
    4. Nature. (2019). Advances in biochemical and biomedical sciences.
    5. Elsevier. (n.d.). Scopus author metrics and citation analysis methodologies.
      https://www.scopus.com

Zerrin Kutlu | Biochemistry, Genetics and Molecular Biology | Research Excellence Award

Published on by Forensic Scientist Awards

Assoc. Prof. Dr. Zerrin Kutlu | Biochemistry, Genetics and Molecular Biology | Research Excellence Award

Ataturk University | Turkey

Assoc. Prof. Dr. Zerrin Kutlu is a leading biochemist whose research focuses on oxidative stress, endoplasmic reticulum (ER) stress, inflammation, and diabetes-related complications, with an emphasis on elucidating molecular mechanisms underlying organ injury and cardiometabolic disorders. Her work spans ischemic heart injury, sepsis-induced organ damage, osteoporosis, and metabolic disease models, highlighting the interplay between oxidative stress and cellular dysfunction. Dr. Zerrin Kutlu has authored 15 Scopus-indexed publications, cited 211 times, with an h-index of 9, reflecting the impact and recognition of her research in the scientific community. She has contributed book chapters and served extensively as a peer reviewer and editorial board member for high-impact journals. Her pioneering studies on avasopasem manganese as a superoxide dismutase mimetic, alongside investigations of ATE1 enzyme biology, have provided novel insights into therapeutic strategies for diabetes, cardiovascular disease, and neurodegenerative disorders. She has advanced translational research through nanotechnology-based drug delivery systems, phenolic compound-loaded nanoparticles, and bioactive natural molecules, demonstrating the therapeutic potential of antioxidant and cytoprotective agents. In collaboration with industry and interdisciplinary teams, Dr. Zerrin Kutlu has developed boron-based bioactive compounds for dermo cosmetic and UV-protective applications, supported by TÜBİTAK-funded projects. Her portfolio includes multiple patents, international publications, and leadership in multi-center experimental studies, underscoring her commitment to innovation and scientific excellence. Through these contributions, Dr. Zerrin Kutlu has significantly advanced understanding of redox biology, ER stress modulation, and translational pharmacology, establishing herself as a recognized leader in biomedical research and therapeutic innovation.

Profiles: Scopus | Google Scholar | ORCID | ResearchGate | LinkedIn

Featured Publications

  • Dumlu, F. A., Aydin, T., Odabasoglu, F., Berktas, O. A., Kutlu, Z., Erol, H. S., … (2019). Anti-inflammatory and antioxidant properties of jervine, a steroidal alkaloid from rhizomes of Veratrum album. Phytomedicine, 55, 191–199.

  • Koc, K., Geyikoglu, F., Cakmak, O., Koca, A., Kutlu, Z., Aysin, F., Yilmaz, A., … (2021). The targets of β-sitosterol as a novel therapeutic against cardio-renal complications in acute renal ischemia/reperfusion damage. Naunyn-Schmiedeberg’s Archives of Pharmacology, 394(3), 469–479.

  • Karaoğlan, E. S., Albayrak, A., Kutlu, Z., & Bayır, Y. (2018). Gastroprotective and antioxidant effects of Eremurus spectabilis Bieb. methanol extract and its isolated component isoorientin on indomethacin-induced gastric damage. Acta Cirúrgica Brasileira, 33, 609–618.

  • Akpinar, E., Kutlu, Z., Kose, D., Aydin, P., Tavaci, T., Bayraktutan, Z., & Yuksel, T. N. (2022). Protective effects of idebenone against sepsis-induced acute lung damage. Journal of Investigative Surgery, 35(3), 560–568.

  • Kutlu, Z., Celik, M., Bilen, A., Halıcı, Z., Yıldırım, S., Karabulut, S., & Karakaya, S. (2020). Effects of umbelliferone isolated from the Ferulago pauciradiata Boiss. & Heldr. plant on cecal ligation and puncture-induced sepsis model in rats. Biomedicine & Pharmacotherapy, 127, 110206.

Huai-Jen Tsai | Biochemistry, Genetics and Molecular Biology | Research Excellence Award

Published on by Forensic Scientist Awards

Prof. Dr. Huai-Jen Tsai | Biochemistry, Genetics and Molecular Biology | Research Excellence Award

Institute of Life Science, Fu-Jen Catholic University | Taiwan

Prof. Dr. Huai-Jen Tsai is a distinguished molecular biologist whose research spans developmental biology, marine biotechnology, and gene transgenesis in aquatic organisms, with a particular focus on zebrafish and other finfish models. He has pioneered innovative sperm-mediated and electroporation-based gene transfer systems, enabling highly efficient transgenesis in finfish and shellfish, and has significantly advanced understanding of growth hormone regulation, gonadotropins, rhodopsins, and muscle-specific transcription factors, thereby contributing to both vertebrate developmental biology and aquaculture applications. Prof. Dr. Huai-Jen Tsai’s work bridges fundamental molecular biology and applied biotechnology, investigating molecular mechanisms regulating embryonic development, stress responses, and neural regeneration, including studies on ENDOU-mediated translation regulation and the role of extracellular proteins in promoting neurite outgrowth and spinal cord repair. He has authored 162 documents indexed in Scopus, which have been cited over 5,174 times by 4,191 publications, and he holds an h-index of 36, reflecting the high impact and wide recognition of his contributions in the scientific community. Throughout his career, Prof. Dr. Huai-Jen Tsai has received numerous prestigious awards, including the MOST Outstanding Research Award, Y. Z. Hsu Technology Invention Award for a patented zebrafish gene fragment, and multiple NSC Outstanding Research Awards, and he has served as principal investigator on numerous funded research projects. In addition, he contributes extensively as a reviewer and editorial board member for international journals. His research continues to integrate molecular genetics, developmental studies, and biotechnological innovation, establishing him as a leading authority in aquatic molecular genetics, transgenic technologies, and regenerative biology, and underscoring his influential role in advancing both basic science and translational applications in vertebrate and aquatic systems.

Profiles: Scopus | ORCID

Featured Publications

  • Lee, H.-C., Huang, Y.-H., Hsieh, C.-C., Ke, Y.-N., & Tsai, H.-J. (2025). ENDOU-1-induced cytoplasmic HnRNPA3 recognizes m6A methylation on the upstream reading frame of human CHOP transcripts to achieve maximal CHOP translation. Preprint.

  • Lee, B.-C., Tsai, J.-C., Huang, Y.-H., Wang, C.-C., Lee, H.-C., & Tsai, H.-J. (2024). The 419th aspartic acid of neural membrane protein enolase 2 is a key residue involved in axonal growth of motor neurons mediated by interaction between enolase 2 receptor and extracellular Pgk1 ligand. International Journal of Molecular Sciences, 25(19), 10753.

  • Lee, H.-C., Chao, H.-T., Lee, S. Y.-H., Lin, C.-Y., & Tsai, H.-J. (2023). The upstream 1350~1250 nucleotide sequences of the human ENDOU-1 gene contain critical cis-elements responsible for upregulating its transcription during ER stress. International Journal of Molecular Sciences, 24(24), 17393.

  • Zeng, C.-W., & Tsai, H.-J. (2023). The promising role of a zebrafish model employed in neural regeneration following a spinal cord injury. International Journal of Molecular Sciences, 24(18), 13938.

  • Fu, C.-Y., Chen, H.-Y., Lin, C.-Y., Chen, S.-J., Sheu, J.-C., & Tsai, H.-J. (2023). Extracellular Pgk1 interacts with neural membrane protein enolase-2 to improve neurite outgrowth of motor neurons. Communications Biology, 6, 822.

Mehrdad Hashemi | Biochemistry, Genetics and Molecular Biology | Best Researcher Award

Published on by Forensic Scientist Awards

Prof. Mehrdad Hashemi | Biochemistry, Genetics and Molecular Biology | Best Researcher Award

Tehran Medical Sciences, Islamic Azad University | Iran

Professor Mehrdad Hashemi is a renowned scholar in Molecular and Medical Genetics whose pioneering research has made transformative contributions to predictive, preventive, and personalized medicine. His scientific work focuses on the discovery of diagnostic and therapeutic biomarkers particularly non-coding RNAs (lncRNAs and miRNAs) with profound implications for early disease detection, molecular targeting, and precision therapy. Prof. Mehrdad Hashemi has authored 372 peer-reviewed publications indexed in Scopus, accumulating over 6,826 citations from 6,242 documents, and achieving a remarkable h-index of 41. His research portfolio includes 299 ISI-indexed papers, 342 Scopus-indexed papers, and 258 PubMed articles, encompassing 119 Q1 and 82 Q2 journals. He has led or completed 14 major research projects, contributed to 95 industrial and academic collaborations, and maintained 110 international research partnerships with leading institutions across the USA, UK, Canada, China, Germany, Australia, and beyond. His scholarly output also includes 3 internationally published books and 1 patent. Ranked among the World’s Top 1% and 2% Scientists in both ESI (2024) and Stanford (2024–2025) global rankings, Prof. Mehrdad Hashemi’s groundbreaking studies on exosomes, nanomedicine, gene regulation, and cancer therapeutics have advanced global understanding of disease mechanisms and innovative treatment modalities. He also contributes extensively as an editorial board member, peer reviewer, and thought leader in the field of molecular diagnostics and translational genetics.

Profiles: Scopus | Google Scholar | ORCID | Staff Page

Featured Publications

  • Paskeh, M. D. A., Entezari, M., Mirzaei, S., Zabolian, A., Saleki, H., Naghdi, M. J., … & Hashemi, M. (2022). Emerging role of exosomes in cancer progression and tumor microenvironment remodeling. Journal of Hematology & Oncology, 15(1), 83. https://doi.org/10.1186/s13045-022-01296-0

  • Bolhassani, A., Javanzad, S., Saleh, T., Hashemi, M., Aghasadeghi, M. R., … & Sadat, S. M. (2014). Polymeric nanoparticles: potent vectors for vaccine delivery targeting cancer and infectious diseases. Human Vaccines & Immunotherapeutics, 10(2), 321–332. https://doi.org/10.4161/hv.26796

  • Entezari, M., Hashemi, D., Taheriazam, A., Zabolian, A., Mohammadi, S., … & Hashemi, M. (2022). AMPK signaling in diabetes mellitus, insulin resistance and diabetic complications: A pre-clinical and clinical investigation. Biomedicine & Pharmacotherapy, 146, 112563. https://doi.org/10.1016/j.biopha.2021.112563

  • Hashemi, M., Moosavi, M. S., Abed, H. M., Dehghani, M., Aalipour, M., Heydari, E. A., … & Mirzaei, S. (2022). Long non-coding RNA (lncRNA) H19 in human cancer: From proliferation and metastasis to therapy. Pharmacological Research, 184, 106418. https://doi.org/10.1016/j.phrs.2022.106418

  • Sadrkhanloo, M., Entezari, M., Orouei, S., Ghollasi, M., Rezaei, S., Hejazi, E. S., … & Hashemi, M. (2022). STAT3-EMT axis in tumors: Modulation of cancer metastasis, stemness and therapy response. Pharmacological Research, 182, 106311. https://doi.org/10.1016/j.phrs.2022.106311

Meng Ning | Biochemistry, Genetics and Molecular Biology | Best Researcher Award

Published on by Forensic Scientist Awards

Dr. Meng Ning | Biochemistry, Genetics and Molecular Biology | Best Researcher Award

Chiba University | China

Dr. Meng Ning is an accomplished researcher at Chiba University, Japan, recognized for her pioneering work in the epigenetic regulation of cancer. She has made substantial contributions to understanding the non-catalytic roles of chromatin regulators, particularly in gastric cancer. Her expertise bridges molecular biology and clinical gastrointestinal oncology, enabling her to translate laboratory discoveries into potential therapeutic strategies. Meng Ning is known for her meticulous experimental design, innovative application of genome-editing technologies, and dedication to advancing cancer research through both independent studies and collaborative projects.

Professional Profile

ORCID

Education

Dr. Meng Ning completed her doctoral studies at Chiba University, Japan, where she focused on elucidating novel mechanisms of cancer progression. Her Ph.D. research revealed a previously unrecognized non-catalytic function of SETD1A in gastric cancer via the E2F4–TAF6 axis. Employing advanced techniques including transcriptomics, epigenomics, and genome-editing approaches, she was able to demonstrate this mechanism independently of traditional methyltransferase activity. Her academic training combines rigorous laboratory research with a strong foundation in clinical oncology, preparing her to conduct translational studies that link fundamental discoveries with therapeutic potential.

Experience

Dr. Meng Ning has extensive experience in both experimental and translational cancer research. She has collaborated with the Department of Pathology at the University of Tokyo to analyze clinical gastric cancer specimens, integrating molecular findings with patient data. Her work spans NGS-based studies, CRISPR genome editing, and multi-omics analyses, reflecting a versatile approach to cancer biology. Beyond laboratory research, she has contributed to the mentorship of junior researchers, participated in collaborative projects across institutions, and actively engaged in the scientific community through professional society memberships and research networks.

Research Interests

Dr. Meng Ning’s primary research interest lies in the epigenetic regulation of cancer, with a focus on non-catalytic functions of chromatin regulators. She investigates how these regulators influence tumor proliferation, cellular signaling, and transcriptional networks using advanced molecular biology techniques. Her research integrates next-generation sequencing, genome editing, and integrative bioinformatics to identify novel mechanisms underlying cancer progression. By connecting these molecular insights with clinical oncology, she aims to identify potential therapeutic targets and contribute to the development of innovative cancer treatments.

Awards

Dr. Meng Ning is nominated for the Best Researcher Award in recognition of her outstanding contributions to cancer epigenetics and translational oncology. Her research has introduced novel concepts in understanding chromatin regulator function and tumor biology, demonstrating originality, technical excellence, and significant impact in the field. Her dedication to advancing cancer research through rigorous experimentation and collaborative endeavors positions her as a leading researcher in her discipline.

Publications

Dr. Meng Ning has authored several high-impact, SCI-indexed publications as first or contributing author. Her work demonstrates innovative methodologies and deep insights into the molecular mechanisms of cancer:

Title: Non-catalytic role of SETD1A promotes gastric cancer cell proliferation through the E2F4–TAF6 axis in the cell cycle
Journal: Cell Death & Disease
Published on: 2025-08-23

Title: Non-enzymatic SETD1A activity drives breast cancer cell proliferation via cyclin K
Journal: Breast Cancer Research
Published on: 2025-08-11

Title: Integrated enhancer regulatory network by enhancer–promoter looping in gastric cancer
Journal: NAR Cancer
Published on: 2024-04-08

Conclusion

Dr. Meng Ning exemplifies excellence in scientific research through her innovative studies in cancer epigenetics and her commitment to translational application. Her work bridges basic molecular discoveries and clinical oncology, offering new avenues for therapeutic development. With a combination of technical skill, collaborative engagement, and visionary research, Meng Ning stands out as a highly deserving candidate for the Best Researcher Award. Her contributions not only advance the understanding of cancer biology but also inspire ongoing innovation in epigenetic and translational research.

Nicolas Leuenberger | Biochemistry, Genetics and Molecular Biology | Best Researcher Award

Published on by Forensic Scientist Awards

Dr. Nicolas Leuenberger | Biochemistry, Genetics and Molecular Biology | Best Researcher Award

Swiss laboratory for Doping Analyses | Switzerland

Dr. Nicolas Leuenberger is a distinguished Privat-docent and Research Manager at the Swiss Laboratory for Doping Analyses, University Hospital of Lausanne. With a proven track record in forensic science and anti-doping research, he has contributed significantly to advancing methodologies for detecting blood doping and other performance-enhancing practices. His leadership in managing research projects, mentoring graduate students, and fostering international collaborations has positioned him as an influential figure in forensic and biomedical sciences.

Professional Profile

Scopus

Education

Dr. Nicolas Leuenberger holds a PhD in Biomedical Sciences and advanced qualifications in forensic and medical sciences, which laid the foundation for his career in anti-doping research. His academic background integrates molecular biology, biochemistry, and forensic medicine, enabling him to explore novel biomarkers of blood manipulation and enhance anti-doping practices worldwide.

Experience

With extensive experience as Research Manager at the Swiss Laboratory for Doping Analyses, Dr. Nicolas Leuenberger oversees both research operations and biological unit management. He directs master’s and PhD projects, guiding students from experimental design to thesis completion. As part of the LAD management team, he coordinates grant applications, establishes ISO-accredited protocols, and supervises multidisciplinary collaborations with hospital units and global anti-doping laboratories. His consultancy roles with Novartis Pharma Schweiz AG, the Research Grants Council of Hong Kong, and the World Anti-Doping Agency further demonstrate his expertise and international recognition.

Research Interests

Dr. Nicolas Leuenberger’s research focuses on the discovery of innovative biomarkers for blood doping, particularly through the fields of ironomics and transcriptomics. His pioneering work on erythroferrone and hepcidin as indicators of blood manipulation has reshaped anti-doping science. Currently, he is advancing mRNA biomarker detection from dried blood spots, enabling more accurate detection of autologous blood transfusions and micro-dose EPO administration. His commitment lies in developing cutting-edge forensic tools that safeguard the integrity of sports and public health.

Awards

Dr. Nicolas Leuenberger has been widely recognized for his contributions to forensic and anti-doping science. His editorial appointment as Associate Editor of Frontiers in Sport and Active Living and his membership in the Swiss Haematology Society underscore his professional standing. He has also been invited as an expert reviewer for the World Anti-Doping Agency and other international bodies, reflecting his global impact on anti-doping policy and scientific innovation.

Publications

Dr. Nicolas Leuenberger has authored over 45 peer-reviewed publications in leading scientific journals, significantly contributing to anti-doping and forensic biomarker research. A selection of his highly cited works includes:

1. Detection of erythropoiesis-stimulating agents in human anti-doping control: Past, present and future
Journal: Drug Testing and Analysis
Published on: July 2012

2. Circulating microRNAs as Biomarkers for Detection of Autologous Blood Transfusion
Journal: PLoS ONE
Published on: June 2013

3. Circulating microRNAs: The Future of Biomarkers in Anti-doping Field
Journal: Drug Testing and Analysis
Published on: December 2015

4. Autologous Blood Transfusion in Sports: Emerging Biomarkers
Journal: Transfusion Medicine Reviews
Published on: May 2016

5. mRNA Biomarkers in Dried Blood Spots May Improve Detection of Autologous Blood Micro-Transfusions Using an Individualized Approach
Journal: Haematologica
Published on: August 2025

6. High Pretransplant Levels of Erythroferrone Are Predictive for 1-Year All-Cause Mortality and Acute Cellular Rejection after Heart Transplantation
Journal: The Journal of Heart and Lung Transplantation
Published on: January 2025

7. New Transcriptomic Biomarkers for Detection of the Recombinant Human Erythropoietin (rHuEPO) MirCERA in Horses
Journal: Frontiers in Veterinary Science
Published on: September 2024

8. Comparison between standard hematological parameters and blood doping biomarkers in dried blood spots within the athlete population of Swiss Sport Integrity
Journal: Haematologica
Published on: September 2024

Conclusion

Dr. Nicolas Leuenberger exemplifies scientific excellence through his pioneering research in anti-doping biomarker discovery, his leadership at the Swiss Laboratory for Doping Analyses, and his dedication to mentoring the next generation of forensic scientists. His contributions have not only advanced the global fight against blood doping but also strengthened the integrity of competitive sports. For these reasons, he is a highly deserving candidate for the Best Researcher Award.

Rui Shi | Chemistry | Best Researcher Award

Published on by Forensic Scientist Awards

Assoc. Prof. Dr. Rui Shi | Chemistry | Best Researcher Award

Dr. Rui Shi is an Associate Researcher and Master’s Supervisor at the Technical Institute of Physics and Chemistry, Chinese Academy of Sciences (CAS) 🧪. A forward-thinking scientist, he is at the forefront of electrocatalytic research aimed at sustainable plastic alternatives. His pioneering work in converting waste PET into polylactic acid (PGA), a biodegradable plastic, positions him as a key contributor to green chemistry and sustainable materials science.

Professional profile👤

Scopus

Strengths for the Awards✨

  • Innovative Research Focus
    Rui Shi’s work on electrocatalytic reforming of waste PET to produce biodegradable polyglycolic acid (PGA) addresses critical global challenges in plastic pollution and sustainable materials. His focus on catalytic stability, selectivity, and conversion efficiency demonstrates a high level of scientific rigor and innovation.

  • Interdisciplinary Impact
    The research intersects materials science, environmental chemistry, and chemical engineering, showcasing a strong interdisciplinary approach. This broad relevance enhances the societal and academic impact of his work.

  • Research Output and Quality
    With over 30 publications in high-impact journals such as Nature Communications, Advanced Materials, and Chemical Science, Rui Shi demonstrates both productivity and excellence. These journals are well-regarded for rigorous peer review and high citation potential.

  • Intellectual Property and Practical Contributions
    The authorization of over 20 Chinese invention patents indicates significant contributions to applied science and technology, suggesting Rui Shi’s work goes beyond theoretical research and into innovation with real-world applications.

  • Leadership and Recognition
    His leadership roles in multiple national-level projects (e.g., National Natural Science Foundation of China, National Key R&D Program) confirm recognition of his expertise and trust in his leadership from major scientific institutions.

🎓 Education

Rui Shi has developed his academic foundation through rigorous training in chemical physics and materials science. His educational path, rooted in some of China’s top institutions, has equipped him with deep theoretical and practical insights into catalysis, chemical reaction engineering, and environmental chemistry.

💼 Experience

Currently serving as an Associate Researcher at CAS, Rui Shi has been instrumental in leading and collaborating on high-impact national and institutional projects. These include the General Program of the National Natural Science Foundation of China, the National Key R&D Program, and initiatives under the Chinese Academy of Sciences and National Defense Science and Technology Innovation Special Zone. His leadership bridges advanced materials research and real-world sustainability applications.

🔬 Research Interest On Chemistry

Rui Shi’s core research interest lies in electrocatalytic reforming of waste plastics, particularly PET, into biodegradable materials like PGA ♻️. His approach integrates catalyst design, surface/interface engineering, and process optimization for enhanced stability, selectivity, and conversion efficiency. His recent work also encompasses the separation and purification of high-purity glycolic acid crystals, contributing to a closed-loop system for plastic waste reuse.

🏅 Awards

Rui Shi has been recognized with funding and leadership roles in major Chinese science programs, including:

  • General Program of the National Natural Science Foundation of China

  • Intellectual Property Special Project of the Chinese Academy of Sciences
    These accolades reflect his excellence in scientific innovation and project leadership at national levels 🏆.

📚 Publications

Rui Shi has published over 30 peer-reviewed articles in top-tier journals, including:

  • Nature Communications (2023): Electrocatalytic PET-to-PGA Pathways — Cited by 100+ articles

  • Advanced Materials (2022): Biodegradable Plastics from Waste: A Catalyst Perspective — Cited by 85+

  • Chemical Science (2021): Catalyst Interface Engineering in Plastic Reforming — Cited by 60+

  • Science China Materials (2020): Separation of Glycolic Acid from Electrocatalysis — Cited by 50+

These works are widely cited and have significantly influenced the direction of research in sustainable catalysis and materials chemistry 🔍.

🔚 Conclusion

Dr. Rui Shi’s interdisciplinary expertise, from catalyst design to waste plastic upcycling, exemplifies innovation in green chemistry 🌍. His scientific leadership and publication record place him among the emerging leaders in sustainable material development. With over 30 high-impact publications and national recognition through competitive grants, Rui Shi continues to drive transformative change in environmental technology and chemical research.